The Penn Cancer Network
An innovative partnership
The Ann B. Barshinger Cancer Institute and Penn Cancer Network partnership brings the resources of two top health systems together in the fight against cancer.
LG Health physician experts and a highly skilled oncology team bring you leading-edge prevention, detection, treatment and survivorship programs. Our medical oncologists and surgeons have been pioneers in treating breast, lung, prostate and gynecologic cancers. Radiation oncologists lead the way in using state-of-the-art technology to more precisely target, and destroy, cancer.
Through the Penn Cancer Network, our ability to offer top-notch cancer goes a step further. Our patients have access to the advanced science of one of the nation's foremost cancer centers, Penn's Abramson Cancer Center in Philadelphia.
Bridging community and subspecialty cancer care
Lancaster General Health was one of the earliest members of the Penn Cancer Network, which currently has 14 members, and is the only member in Lancaster County. The Ann B. Barshinger Cancer Institute is built on a National Cancer Institute model for a community cancer center, which recognizes that most cancer treatment will remain local.
However, when subspecialty care is needed, the Penn Cancer Network partnership ensures timely second opinions and referrals to Penn's Abramson Cancer Center for the small percentage of tough, complex cancers. When conventional treatment is exhausted, the Abramson Cancer Center can offer unique Phase 1 studies to enable LG Health patients to receive state-of-the-art care. The goal is to ensure seamless coordination and a return to Lancaster General Health for ongoing care.
The benefits of advanced science
Through the Penn Cancer Network, we provide access to Penn's extensive clinical trials program offering Phase II and Phase III national clinical trials. These trials are used to evaluate the safety and effectiveness of a drug and to compare new treatments with the current standards. Your physician can explain the risks and benefits of research participation and identify any trials that might be a good fit for you.
Together, we work toward goals such as moving molecular medicine—treating cancer by understanding what is happening within genes—closer to home. One example is the genetic testing now available locally via Penn Medicine's Cancer Risk Evaluation Program at Lancaster General Health. Our physicians, and therefore our patients, benefit from close collaboration with their University of Pennsylvania counterparts in the particular subspecialties in which Penn oncologists excel.
Click to learn more:
Penn Cancer Network
Abramson Cancer Center